Elevated levels of vitamin D and deficiency of mannose binding Lectin in dengue hemorrhagic fever

Virology Journal

Volumn 9, Issue , 2012, Pages

  Alagarasu, Kalichamy ^a   Bachal, Rupali V ^a   Bhagat, Asha B ^a   Shah, Paresh S ^a   Dayaraj, Cecilia ^a  

^a NATIONAL INSTITUTE OF VIROLOGY   (India)

Author keywords

Dengue; DF; DHF; Mannose binding lectin; Vitamin D

Indexed keywords

MANNOSE BINDING LECTIN; VITAMIN D;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DENGUE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE STATUS; MAJOR CLINICAL STUDY; MALE; PRIMARY INFECTION; PROTEIN BLOOD LEVEL; PROTEIN DEFECT; SCHOOL CHILD; SECONDARY INFECTION; VITAMIN BLOOD LEVEL; BLOOD; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DENGUE HEMORRHAGIC FEVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; VITAMIN D; YOUNG ADULT;

EID: 84860523080     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-86     Document Type: Article

References (38)

1. DGHS, Guidelines for Prevention and Control of Dengue Zoonosis division, National Institute of Communicable diseases, Govt of India 2006
2. Dengue Virus Pathogenesis: an integrated view. Martina BE, Koraka P, Osterhaus AD, Clinical Microbiology Reviews 2009 22 4 564 581 10.1128/CMR.00035-09 19822889
3. T lymphocyte response to heterologus secondary dengue virus infections. Rothman AL, Ann NY Acad Sci 2009 1171 36 E41 19751400
4. Antibodies determine virulence in dengue. Halstead SB, Ann NY Acad Sci 2009 1171 48 E56 19751402
5. Clinical Findings and Pro-Inflammatory Cytokines in Dengue Patients in Western India: A Facility-Based Study. Priyadarshini D, Gadia RR, Tripathy A, Gurukumar KR, Bhagat A, Patwardhan S, Mokashi N, Vaidya D, Shah PS, Cecilia D, PLoS ONE 2010 5 1 8709 10.1371/journal.pone.0008709 20090849
6. Elevated levels of IL-8 in dengue hemorrhagic fever. Raghupathy R, Chaturvedi UC, Al-Sayer H, Elbishbishi EA, Agarwal R, Nagar R, Kapoor S, Misra A, Mathur A, Nusrat H, Azizieh F, Khan MA, Mustafa AS, J Med Virol 1998 56 3 280 285 10.1002/(SICI)1096-9071(199811)56:3<280::AID-JMV18>3.0.CO;2-I 9783699 (Pubitemid 28458099)
7. Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. Braga EL, Moura P, Pinto LM, Ignacio SR, Oliveira MJ, Cordeiro MT, Kubelka CF, Mem Inst Oswaldo Cruz 2001 96 229 232 10.1590/S0074-02762001000200015 11285501 (Pubitemid 33640932)
8. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, Assis EF, Bozza PT, Kubelka CF, BMC Infect Dis 2008 8 86 10.1186/1471-2334-8-86 18578883
9. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, Liu HS, Lin YS, Wang ST, Shyu HW, Yeh TM, Am J Trop Med Hyg 2006 74 142 147 16407359
10. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Azeredo EL, Zagne SM, Santiago MA, Gouvea AS, Santana AA, Neves-Souza PC, Nogueira RM, Miagostovich MP, Kubelka CF, Immunobiology 2001 204 494 507 10.1078/0171-2985-00058 11776403 (Pubitemid 33138110)
11. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Rothman AL, Ennis FA, J Med Virol 1999 59 329 334 10.1002/(SICI)1096-9071(199911)59:3<329::AID-JMV12>3.0.CO;2-G 10502265 (Pubitemid 29468075)
12. Vitamin D and the antiviral state. Beard AJ, Bearden A, Striker R, J Clin Virology 2011 50 194 200 10.1016/j.jcv.2010.12.006
13. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. Liu PT, Stenger S, Tang DH, Modlin RL, J Immunol 2007 179 2060 2063 17675463
14. Vitamin effects on the immune system: vitamins A and D take centre stage. Mora RJ, Iwata M, von Andrian HU, Nat Reviews Immunol 2008 8 685 698 10.1038/nri2378
15. 1alpha,25- Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, OGarra A, J Immunol 2001 167 4974 4980 11673504 (Pubitemid 33009728)
16. 1, 25 Dihydroxyvitamin D3 modulated cytokine response in pulmonary tuberculosis. Vidyarani M, Selvaraj P, Jawahar MS, Narayanan PR, Cytokine 2007 40 128 134 10.1016/j.cyto.2007.08.005 17911026 (Pubitemid 350180529)
17. Vitamin D and prevention of colorectal cancer. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, Newmark HL, Giovannucci E, Wei M, Holick MF, J Steroid Biochem Mol Biol 2005 97 1-2 179 194 16236494 (Pubitemid 41546228)
18. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Nnoaham KE, Clarke A, Int J Epidemiol 2008 37 113 119 18245055 (Pubitemid 351228619)
19. Immunophenotype of vitamin D receptor polymorphism associated to risk of HIV-1 infection and rate of disease progression. Torres C, Sánchez de la Torre M, García-Moruja C, Carrero AJ, Trujillo Mdel M, Fibla J, Caruz A, Curr HIV Res 2010 8 487 492 10.2174/157016210793499330 20642435
20. - 1 alpha, 25-dihydroxyvitamin D3 and its analogues modulate the phagocytosis of human monocyte-derived dendritic cells. Zhu KJ, Zhou WF, Zheng M, Yao Xue Xue Bao 2002 37 94 97 12579950
21. Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): a morphologic, phenotypic, and functional analysis. Rigby WF, Shen L, Ball ED, Guyre PM, Fanger MW, Blood 1984 64 1110 1115 6548394 (Pubitemid 15212056)
22. Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin D receptor and FC gamma receptor IIA genes. Loke H, Bethell D, Phuong CXT, Day N, White N, Farrar J, Hill A, Am J Trop Med Hyg 2002 67 102 106 12363051 (Pubitemid 35034327)
23. The role of mannose Binding Lectin in innate immunity. Takahashi K, Ezekowitz RAB, Clinical Infectious Diseases 2005 41 440 S444 10.1086/431987 16237644 (Pubitemid 41598302)
24. Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin. Fuchs A, Lin TY, Beasley DW, Stover CM, Schwaeble WJ, Pierson TC, Diamond MS, Cell Host Microbe 2010 8 186 195 10.1016/j.chom.2010.07.007 20709295
25. MBL2 gene polymorphisms protect against development of thrombocytopenia associated with severe dengue phenotype. Acioli-Santos B, Segat L, Dhalia R, Brito CAA, Braga-Neto UM, Marques ET, Crovella S, Hum Immunol 2008 69 2 122 128 10.1016/j.humimm.2008.01.005 18361938
26. Alternative Complement Pathway Deregulation Is Correlated with Dengue Severity. Nascimento EJM, Silva AM, Cordeiro MT, Brito CA, Gil LHVG, Brago-Neto U, Marques ETA, PLoS ONE 2009 4 8 6782 10.1371/journal.pone.0006782 19707565
27. World Health Organisation, Prevention and control of Dengue and Dengue haemorrhagic fever: Comprehensive guidelines WHO Regional Publication, 1999 SEARO No. 29:pp 11-pp 19
28. Detection of dengue-4 virus in Pune, western india after an absence of 30years - its association with two severe cases. Cecilia D, Kakade MB, Bhagat AB, Vallentyne J, Singh A, Patil JA, Todkar SM, Varghese SB, Shah PS, Virology J 2011 8 46 10.1186/1743-422X-8-46
29. High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, Packe GE, Moore-Gillon JC, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Woodward NJ, Venton TR, Barnes KE, Mullett CJ, Coussens AK, Rutterford CM, Mein CA, Davies GR, Wilkinson RJ, Nikolayevskyy V, Drobniewski FA, Eldridge SM, Griffiths CJ, Lancet 2011 377 9761 242 250 10.1016/S0140-6736(10)61889-2 21215445
30. Serum levels of Mannan-binding lectin in patients with Crimean-Congo hemorrhagic fever. Engin A, Ugurlu S, Caglar E, Oztop AY, Inan D, Elaldi N, Dokmetas I, Bakir M, Vector Borne Zoonotic Dis 2010 10 10 1037 1041 10.1089/vbz.2009.0060 20426687
31. Serum mannose-binding lectin levels are linked with respiratory syncytial virus (RSV) disease. Ribeiro LZ, Tripp RA, Rossi LM, Palma PV, Yokosawa J, Mantese OC, Oliveira TF, Nepomuceno LL, Queiráz DA, J Clin Immunol 2008 28 2 166 173 10.1007/s10875-007-9141-8 17952574 (Pubitemid 351328951)
32. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. Ip WK, Chan KH, Law HK, Tso GH, Kong EK, Wong WH, To YF, Yung RW, Chow EY, Au KL, Chan EY, Lim W, Jensenius JC, Turner MW, Peiris JS, Lau YL, J Infect Dis 2005 191 10 1697 1704 10.1086/429631 15838797 (Pubitemid 40656758)
33. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. Avirutnan P, Fuchs A, Hauhart RE, Somnuke P, Youn S, Diamond MS, Atkinson JP, J Exp Med 2010 207 793 806 10.1084/jem.20092545 20308361
34. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S, Chansiriwongs W, Vaughn DW, Nisalak A, Ennis FA, Rothman AL, J Infect Dis 2002 185 1213 1221 10.1086/340365 12001037 (Pubitemid 34439127)
35. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A, J Infect Dis 2000 181 2 9 10.1086/315215 10608744 (Pubitemid 30049026)
36. Complement-mediated neutralization of dengue virus requires mannose-binding lectin. Avirutnan P, Hauhart RE, Marovich MA, Garred P, Atkinson JP, Diamond MS, M Bio 2011 2 6 00276 e00211 22167226
37. Low serum mannose binding lectin levels increases the risk of death due to pneumococcal infection. Eisen DP, Dean MM, Boemeester MA, Fidler KJ, Gordon AC, Kronborg G, Kun JFJ, Lau YL, Payeras A, Valdimarsson H, Brett SJ, Eddie Ip WK, Mila J, Peters MJ, Saevarsdottir S, van Till JW Oliver, Hinds CJ, McBryde ES, Clin Infect Dis 2008 47 510 516 10.1086/590006 18611155
38. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Faul F, Erdfelder E, Lang A-G, Buchner A, Behavior Research Methods 2007 39 175 191 10.3758/BF03193146 17695343